
    
      Patients with Peripheral T-cell lymphoma usually have a bad prognosis. These patients cannot
      be treated successfully with the conventional chemotherapy of CHOP. The investigators have
      been proceeding this trial to evaluate the efficacy and safety of the combination
      chemotherapy regiment GDPT regiment (gemcitabineï¼Œcisplatin,Prednisone ,Thalidomide

      ) in the patients with Peripheral T-cell lymphoma.
    
  